Crossmark

Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancer

Crossref DOI link: https://doi.org/10.1016/j.remnie.2023.06.005

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vidal, M.

Cárdenas-Perilla, R.

Delgado, A.

Morón, S.

Londoño Blair, J.L.

Vega, I.

Correa Ochoa, J.J.

Rojas, J.
License Information

Text and Data Mining valid from 2023-09-01
More Information

This article is maintained by: Elsevier

Article Title: Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancer

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2023.06.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2023.06.004

Content Type: article

Copyright: © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.